29 results on '"Esteva De Antonio I"'
Search Results
2. Nuevos modelos de atención sanitaria para las personas transgénero en el Sistema Sanitario Español: demandas, controversias y reflexiones
- Author
-
Gómez-Gil E, Esteva de Antonio I, Fernández Rodríguez M, Almaraz Almaraz M, Hurtado Murillo F, Gómez Balaguer M, Asenjo Araque N, Mora Porta M, Halperin Rabinovich I, Fernández García R, Montejo González ÁL, and Gidseen G
- Subjects
Gender units ,Gender incongruence ,Health care model ,Spain ,Spanish National Health Service ,Transgender ,Gender variant ,Gender dysphoria ,Transsexualism - Abstract
Health care for transgender people in Spain has been progressively established since 1999 when the first multidisciplinary unit for the treatment of sex reassignment was created in Andalusia. In this document, the social changes, the demands and debates of users and professionals, the new models of health care for trans people, and reflections on the current situation, have been analysed. The social openness in Spain regarding sexual and gender diversity has evolved quite positively. The health demands of the transgender users are not uniform and do not always match with the criteria of the professionals. In some Spanish regions, health care is distancing itself from the internationally recommended multidisciplinary model. The new healthcare models have been established under the aegis of primary care and/or endocrinologist in the area, without a required psychological assessment. The main contributing factors for this change of model have been the pressure from some associations with demands for "depathologization" and "decentralization". The professionals of gender units, while recognizing the need for a broader vision of trans reality, warn of the risk of treating trans people without the involvement of mental health specialists or by professionals in proximity with little experience. Moreover, the decentralization would not allow acting on large cohorts, which hinders the advance of knowledge and contrasted evaluations with neighbouring countries. In summary, the new health models, although intended to facilitate care through proximity, do not guarantee improvements in quality and difficult to make a comparative evaluation of the results.
- Published
- 2020
3. Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- Author
-
James, Wp, Caterson, Id, Coutinho, W, Finer, N, VAN GAAL LF, Maggioni, Ap, TORP-PEDERSEN, C, Sharma, Am, Shepherd, Gm, Rode, Ra, Renz, Cl, Van Gaal LF, Torp-Pedersen, C, Pepine, C, Pocock, S, Drexler, H, Swedberg, K, Sleight, P, Armstrong, P, Kerr, D, Dagenais, G, Brophy, J, Avezum, A, Bogaty, P, Fabbri, G, Galli, M, Hildebrandt, P, Mann, J, Ostergren, J, Sherman, D, Zannad, F, Colquhoun, D, Hollanders, G, e Forti A, Costa, Cifkova, R, Toubro, S, Ziegler, O, Scherbaum, Wa, Jordan, J, Halmy, L, Ferrannini, E, Santini, F, Gonzalez, C, Narkiewicz, K, Hancu, N, Payer, J, Pascual, J, Wilding, J, Campbell, L, Carey, D, Gerstman, M, Karrasch, J, Lefkovits, J, Marks, J, Marks, S, Moses, R, Phillips, P, Proietto, J, Roberts, D, Roberts-Thomson, P, Shaw, J, Simpson, R, Singh, B, Singleton Jeffries, W, Stuckey, B, Boland, J, Brohet, C, Coucke, F, Dendale, P, Jouret, G, Kolanowski, J, Kutnowski, M, Martens, F, Muls, E, Peiffer, F, Penninckx, H, Scheen, A, Schoors, D, Vaerenberg, M, Van Cleemput, J, Van Crombrugge, P, Van Kuyk, M, Verhaegen, A, Wollaert, B, de Albuquerque DC, Appolinario, J, de Godoy Matos AF, Gross, Jl, Halpern, A, Kerr Saraiva JF, Milagres, R, Repetto, G, Suplicy, Hl, Zanella, Mt, Bednarova, J, Cepelak, V, Cerny, P, Hainer, V, Havranek, P, Homza, M, Jansa, P, Karlicek, M, Kolesar, J, Kotik, I, Kucera, D, Kuchar, J, Kunc, M, Kvapil, M, Linhart, A, Machova, V, Matuska, J, Oral, I, Pavlas, J, Pesatova, S, Povolny, J, Semrad, B, Smetana, K, Soucek, M, Svacina, S, Tesinsky, P, Urbanek, R, Wasserburger, B, Zachoval, R, Zahumensky, E, Zidkova, E, Astrup, A, Dominguez, H, Faber, J, Hilderbrant, P, Kober, L, Perrild, H, Richelsen, B, Sogaard, P, Svendsen, Ol, Urhammer, S, Archambeaud, F, Basdevant, A, Borys, Jm, Bringer, J, Brunetiere, C, Charpentier, G, Cocaul-André, M, Dabadie, H, Dubreuil, A, Estour, B, Gautier, Jf, Gibault, T, Halimi, S, Hespel, Jp, Issa Sayegh, M, Krempf, M, Laville, M, Lecerf, Jm, Louvet, Jp, Penfornis, A, Ritz, P, Schlienger, Jl, Schmitt, B, Valensi, P, Baar, M, Beermann, J, Bock, M, Boenner, G, Dammann, Hg, Diehm, C, Ditschuneit, H, Gadow, J, Gehlhar, S, Gessner, S, Guthersohn, A, Hamann, A, Hanefeld, M, Hasenfuss, G, Herzner, A, Heun, Kc, Heufelder, Ae, Hohensee, H, Jacob, S, Krings, P, Krätzig, B, Krosse, B, Lehmann, Rt, Mindt-Prüfert, S, Maisch, B, Pfeiffer, Af, Richard, F, Rose, B, Schmidt, E, Scholze, J, Schreckenberg, A, Stuebler, P, Walter, J, Wirth, A, Wunderlich, J, Abraham, G, Altorjay, A, Augusztin, G, Csaszar, A, Czuriga, I, Dinnyes, J, Gero, L, Gyimesi, A, Janosi, A, Kovacs, I, Liziczai, I, Majtenyi, A, Medvegy, M, Nadhazi, Z, Pados, G, Polak, G, Ronaszeki, A, Sido, Z, Simon, K, Anzà, C, Bevilacqua, M, Bosello, O, Chiariello, M, Cordera, R, Ferrari, E, Frittitta, L, Giorgino, R, Liuzzi, A, Malinverni, C, Di Mario, U, Melchionda, N, Occhi, G, Perticone, F, Pinchera, A, Pinelli, G, Rovera, G, Santeusanio, F, Urbinati, S, Alpizar-Salazar, M, Carrillo-Ortega, E, Fanghanel Salmon, G, Laviada-Molina, Ha, Madero, Ma, Rodriguez, G, Saldate, C, Sanchez-Castillo, Cp, Violante, Rm, Wacher, N, Zayas-Jaime, Fj, Zuniga-Guajardo, S, Adamiec, R, Banasiak, W, Chrusciel, P, Derlaga, B, Gebala, A, Gessek, J, Janik, K, Janion, M, Kalina, Z, Kozlowski, A, Kusnierz, B, Majcher, Z, Miekus, P, Niegowska, J, Okopien, B, Ostrowska, L, Pasowicz, M, Piepiorka, M, Pluta, W, Polaszewska-Muszynska, M, Ponikowski, P, Pupek-Musialik, D, Sawicki, A, Sobocik, H, Stankiewicz, A, Szpajer, M, Trojnar, R, Tykarski, A, Wrabec, K, Wyrzkowski, B, Zahorska-Markiewicz, B, Zalewski, M, Carrageta, M, Mendes Pedro MM, Parente Martins LM, dos Santos, L, Babes, A, Creteanu, G, Dan, Ga, Dragulescu, Si, Graur, M, Tirgoviste, Ci, Morosanu, M, Mota, M, Paveliu, Fs, Radoi, M, Ranetti, A, Totoian, I, Andre, I, Bugan, V, Cencarik, J, Csala, L, Farsky, S, Gonsorcik, J, Kamensky, G, Kmec, J, Krahulec, B, Kurian, R, Macek, V, Majercak, I, Micko, K, Mokan, M, Riecansky, I, Sojka, G, Uhliar, R, Urgeova, L, Vancik, J, Baro, Fm, Barrios Merino, A, Borras, Jl, Caixas, A, Cuatrecasas Cambra, G, Dominguez Escribano JR, Duran Garcia, S, Escobar-Jimenez, L, Esteva de Antonio, I, Formiguera Sala, X, Garcia-Luna, Pp, Garcia Robles, R, Gonzalez Albarran, O, Hernandez-Mijares, A, Martin Hidalgo, A, Masmiquel Comas, L, Morales Perez, F, Moreno Esteban, B, Pascual Izuel JM, Redon Mas, J, Ricart, W, Rubio, Ma, Ruilope, Lm, Salas-Salvado, J, Terroba Larumbe, M, Tinahones, F, de la Torre Casares ML, Vidal Cortada, J, Zuniga-Perez Lemaur, M, Abdulhakim, Ee, Adler, A, Barnett, Ah, Bodmer, C, Campbell, Iw, Chowdhury, T, Cleland, J, Cook, Rc, Dinneen, S, Donnachie, H, Haslam, Dw, Hillis, Gs, Horne, M, Howarth, Dj, Hughes, E, Jackson, S, Jones, Sc, Jones, Th, Kumar, S, Lean, M, Maroni, J, Mcinnes, G, Middleton, A, Morris, A, Newcombe, G, O'Kane, Kp, Pavel, Ic, Pawa, R, Perry, C, Pitts, C, Raja, A, Reckless, J, Robinson, J, Sarmiento, R, Soo, Sc, Taylor, S, Thomas, Ho, Thomson, Ma, and Wilkins, M.
- Subjects
Male ,medicine.medical_specialty ,Myocardial Infarction ,Blood Pressure ,Kaplan-Meier Estimate ,Type 2 diabetes ,Klinikai orvostudományok ,Placebo ,law.invention ,Double-Blind Method ,Randomized controlled trial ,Weight loss ,law ,Internal medicine ,Appetite Depressants ,medicine ,Humans ,Obesity ,Myocardial infarction ,Stroke ,Aged ,business.industry ,Hazard ratio ,Orvostudományok ,General Medicine ,Middle Aged ,Overweight ,medicine.disease ,Surgery ,Diabetes Mellitus, Type 2 ,Cardiovascular Diseases ,Cardiology ,Female ,Human medicine ,medicine.symptom ,business ,Cyclobutanes ,Sibutramine ,medicine.drug - Abstract
Background The long-term effects of sibutramine treatment on the rates of cardiovascular events and cardiovascular death among subjects at high cardiovascular risk have not been established. Methods We enrolled in our study 10,744 overweight or obese subjects, 55 years of age or older, with preexisting cardiovascular disease, type 2 diabetes mellitus, or both to assess the cardiovascular consequences of weight management with and without sibutramine in subjects at high risk for cardiovascular events. All the subjects received sibutramine in addition to participating in a weight-management program during a 6-week, single-blind, lead-in period, after which 9804 subjects underwent random assignment in a double-blind fashion to sibutramine (4906 subjects) or placebo (4898 subjects). The primary end point was the time from randomization to the first occurrence of a primary outcome event (nonfatal myocardial infarction, nonfatal stroke, resuscitation after cardiac arrest, or cardiovascular death). Results The mean duration of treatment was 3.4 years. The mean weight loss during the lead-in period was 2.6 kg; after randomization, the subjects in the sibutramine group achieved and maintained further weight reduction (mean, 1.7 kg). The mean blood pressure decreased in both groups, with greater reductions in the placebo group than in the sibutramine group (mean difference, 1.2/1.4 mm Hg). The risk of a primary outcome event was 11.4% in the sibutramine group as compared with 10.0% in the placebo group (hazard ratio, 1.16; 95% confidence interval [CI], 1.03 to 1.31; P=0.02). The rates of nonfatal myocardial infarction and nonfatal stroke were 4.1% and 2.6% in the sibutramine group and 3.2% and 1.9% in the placebo group, respectively (hazard ratio for nonfatal myocardial infarction, 1.28; 95% CI, 1.04 to 1.57; P=0.02; hazard ratio for nonfatal stroke, 1.36; 95% CI, 1.04 to 1.77; P=0.03). The rates of cardiovascular death and death from any cause were not increased. Conclusions Subjects with preexisting cardiovascular conditions who were receiving long-term sibutramine treatment had an increased risk of nonfatal myocardial infarction and nonfatal stroke but not of cardiovascular death or death from any cause. (Funded by Abbott; ClinicalTrials.gov number, NCT00234832.)
- Published
- 2010
- Full Text
- View/download PDF
4. Position statement: Gender dysphoria in childhood and adolescence. Working Group on Gender Identity and Sexual Development of the Spanish Society of Endocrinology and Nutrition (GIDSEEN)
- Author
-
Esteva de Antonio I, Asenjo Araque N, Hurtado Murillo F, Fernández Rodríguez M, Vidal Hagemeijer Á, Moreno-Pérez O, Lucio Pérez MJ, López Siguero JP, and Grupo GIDSEEN
- Subjects
Statement ,Childhood and adolescence ,Gender dysphoria - Abstract
Gender dysphoria (GD) in childhood and adolescence is a complex condition where early detection and comprehensive treatment are essential to improve quality of life, decrease mental comorbidity, and improve GD. In this position statement, the Working Group on Gender Identity and Sexual Development of the Spanish Society of Endocrinology and Nutrition (GIDSEEN), consisting of specialists in Endocrinology, Psychology, Psychiatry, Pediatrics and Sociology, sets out recommendations for evaluation and treatment of GD in children and adolescents. Interdisciplinary management of GD should be carried out at specialized units (UTIGs), considering that any clinical intervention should follow the principles of scientific rigor, experience, ethical and deontological principles, and the necessary caution in front of chronic, aggressive, and irreversible treatments. (C) 2015 SEEN. Published by Elsevier Espana, S.L.U. All rights reserved.
- Published
- 2015
5. Reply to: Comments on the 'Clinical practice guidelines for assessment and treatment of transsexuality' issued by the Sexual Identity and Differentiation Group of the SEEN (GIDSEEN)
- Author
-
Moreno-Pérez O and Esteva de Antonio I
- Published
- 2014
6. Guías de práctica clínica para la valoración y tratamiento de la transexualidad. Grupo de Identidad y Diferenciación Sexual de la SEEN (GIDSEEN)*(anexo 1)
- Author
-
Moreno-Pérez O and Esteva De Antonio I
- Abstract
Transsexual patients can only be diagnosed and treated at functional gender identity Units with provision of high quality care, development of clinical practice guidelines, and interdisciplinary working groups. The therapeutic process has three mainstays: initial psychological diagnostic evaluation and psychotherapy, endocrinological evaluation and hormone therapy, and sex reassignment surgery. Cross-sex hormone therapy is essential for the anatomical and psychological transition process in duly selected patients. Hormones help optimize real-life sex identity, improve quality of life, and limit psychiatric co-morbidities often associated to lack of treatment. Development of this clinical practice guideline addresses the need for implementing a coordinated action protocol for comprehensive health care for transgender people in the National Health System.
- Published
- 2012
7. Unidad de trastornos de identidad de género de Andalucía. Experiencia del primer año de funcionamiento
- Author
-
Crespillo Gómez, C., primary, Esteva de Antonio, I., additional, Bergero Miguel, T., additional, Giraldo Ansio, F., additional, Cano Oncala, G., additional, Ruiz de Adana, S., additional, and Soriguer Escofet, F.J.C., additional
- Published
- 2002
- Full Text
- View/download PDF
8. Unsaturated fatty acids alter the insulin secretion response of the islets of Langerhans in vitro
- Author
-
Pareja, A, primary, Tinahones, F.J, additional, Soriguer, F.J, additional, Monzón, A, additional, Esteva de Antonio, I, additional, Garcı́a-Arnes, J, additional, Olveira, G, additional, and Ruiz de Adana, M.S, additional
- Published
- 1997
- Full Text
- View/download PDF
9. Adipose tissue fatty acids and size and number of fat cells from birth to 9 years of age—A cross-sectional study in 96 boys
- Author
-
Soriguer Escofet, F.J.C., primary, Esteva de Antonio, I., additional, Tinahones, F.J., additional, and Pareja, A., additional
- Published
- 1996
- Full Text
- View/download PDF
10. [New care models for transgender people in the Spanish Health System: demands, controversies and reflections.]
- Author
-
Gómez-Gil E, Esteva de Antonio I, Fernández Rodríguez M, Almaraz Almaraz M, Hurtado Murillo F, Gómez Balaguer M, Asenjo Araque N, Mora Porta M, Halperin Rabinovich I, Fernández García R, Montejo González ÁL, and Gidseen G
- Subjects
- Endocrinologists, Female, Gender Identity, Health Services Research, Humans, Interdisciplinary Communication, Male, Sexual Behavior, Spain epidemiology, Primary Health Care organization & administration, Transgender Persons psychology, Transsexualism psychology, Transsexualism therapy
- Abstract
Health care for transgender people in Spain has been progressively established since 1999 when the first multidisciplinary unit for the treatment of sex reassignment was created in Andalusia. In this document, the social changes, the demands and debates of users and professionals, the new models of health care for trans people, and reflections on the current situation, have been analysed. The social openness in Spain regarding sexual and gender diversity has evolved quite positively. The health demands of the transgender users are not uniform and do not always match with the criteria of the professionals. In some Spanish regions, health care is distancing itself from the internationally recommended multidisciplinary model. The new healthcare models have been established under the aegis of primary care and/or endocrinologist in the area, without a required psychological assessment. The main contributing factors for this change of model have been the pressure from some associations with demands for "depathologization" and "decentralization". The professionals of gender units, while recognizing the need for a broader vision of trans reality, warn of the risk of treating trans people without the involvement of mental health specialists or by professionals in proximity with little experience. Moreover, the decentralization would not allow acting on large cohorts, which hinders the advance of knowledge and contrasted evaluations with neighbouring countries. In summary, the new health models, although intended to facilitate care through proximity, do not guarantee improvements in quality and difficult to make a comparative evaluation of the results.
- Published
- 2020
11. Sociodemographic Characteristics and Psychological Adjustment Among Transsexuals in Spain.
- Author
-
Guzmán-Parra J, Sánchez-Álvarez N, de Diego-Otero Y, Pérez-Costillas L, Esteva de Antonio I, Navais-Barranco M, Castro-Zamudio S, and Bergero-Miguel T
- Subjects
- Adult, Female, Gender Identity, Humans, Male, Sexual Behavior psychology, Spain, Surveys and Questionnaires, Young Adult, Adaptation, Psychological, Transsexualism psychology
- Abstract
This study examined the sociodemographic characteristics and the psychological adjustment of transsexuals in Andalusia (Spain), and also analyzed the differences between female-to-male (FtM) and male-to-female (MtF) transsexuals. The sample included 197 transsexuals (101 MtF and 96 FtM) selected from those who visited the Transsexual and Gender Identity Unit at the Carlos Haya Hospital in Malaga between 2011 and 2012. Our analyses indicated that MtF transsexuals were more likely to have lower educational levels, live alone, have worked less frequently throughout their lifetime, and have engaged in prostitution. For FtM transsexuals, there were more frequent references to the mother's psychiatric history and more social avoidance and distress. Multivariate analysis showed that the number of personality dysfunctional traits and unemployment status were associated with depression in the entire sample. The following three conclusions can be made: there are significant differences between MtF and FtM transsexuals (mainly related to sociodemographic variables), depression was high in both groups, and a remarkable percentage of transsexuals have attempted suicide (22.8 %) or have had suicidal thoughts (52.3 %).
- Published
- 2016
- Full Text
- View/download PDF
12. Night-time sleep duration and the incidence of obesity and type 2 diabetes. Findings from the prospective Pizarra study.
- Author
-
Gutiérrez-Repiso C, Soriguer F, Rubio-Martín E, Esteva de Antonio I, Ruiz de Adana MS, Almaraz MC, Olveira-Fuster G, Morcillo S, Valdés S, Lago-Sampedro AM, García-Fuentes E, and Rojo-Martínez G
- Subjects
- Adult, Diabetes Mellitus, Type 2 epidemiology, Female, Humans, Incidence, Male, Middle Aged, Obesity epidemiology, Prospective Studies, Sleep, Time Factors, Diabetes Mellitus, Type 2 etiology, Obesity etiology, Sleep Deprivation complications
- Abstract
Background: Several recent studies have related short sleep duration with different health problems, though the results related with the risk of obesity and type 2 diabetes (T2D) are far from conclusive. The aim of this study was to investigate the association between night-time sleep duration and the incidence of obesity and T2D in a prospective study with a follow-up of 11 years., Material and Methods: The study comprised 1145 people evaluated in 1997-1998 and re-evaluated after 6 years and 11 years. At the three study points, subjects without known diabetes mellitus (KDM) were given an oral glucose tolerance test (OGTT). Anthropometric and biochemical variables were measured. The subjects were asked about their number of hours of night-time sleep., Results: After adjustment, the OR of becoming obese was significantly higher in subjects who slept ≤ 7 hours per night, at both the 6-year follow-up (OR = 1.99; 95% CI = 1.12-3.55) and the 11-year follow-up (OR = 2.73; 95% CI = 1.47-5.04). The incidence of T2D at the 6-year follow-up in subjects without T2D at baseline was higher in those who slept ≤ 7 hours per night (OR = 1.96; 95% CI = 1.10-3.50). However, this association was not independent of obesity, weight gain or abnormal glucose regulation at baseline. At the 11-year follow-up however there was no association between night-time sleep duration and the incidence of T2D., Conclusions: The incidence of obesity over the 11-year follow-up increased in subjects with fewer hours of night-time sleep. The incidence of T2D according to the hours of night-time sleep depended on obesity and the carbohydrate metabolism phenotype., (Copyright © 2014 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
13. Temperament and character in transsexuals.
- Author
-
Gómez-Gil E, Gutiérrez F, Cañizares S, Zubiaurre-Elorza L, Monràs M, Esteva de Antonio I, Salamero M, and Guillamón A
- Subjects
- Adult, Case-Control Studies, Female, Humans, Male, Personality, Personality Disorders, Sexual Behavior, Young Adult, Character, Gender Identity, Personality Inventory statistics & numerical data, Temperament, Transsexualism psychology
- Abstract
The aim of this study was to evaluate personality in transsexuals. The Temperament and Character Inventory (TCI) profiles of 166 male-to-female (MF) and 88 female-to-male (FM) transsexuals were compared with those of a control group of males and females. MF and FM transsexuals scored significantly lower than males and females in RD4 (more independent) and C3 (more self-centeredness). MF transsexuals scored higher than males and females in HA4 (more fatigable), ST and ST3 (more spiritual acceptance), and lower in C5 (more opportunistic); moreover, they showed higher scores than males in RD1 (more sentimental) and lower than females in C (less cooperativeness). FM transsexuals scored lower than females in HA2 (more daring and confident), RD (less sentimental), and C5 (more opportunistic). Compared with FM, MF transsexuals scored higher on HA2 (more fearful), RD, RD1 (more sentimental), ST, ST2 and ST3 (more spiritual). All these differences were less than half a standard deviation except for C3. Data show that transsexuals and controls display a similar personality profile, even though there are some differential personality traits. Moreover, the personality profile of transsexuals was closer to the profile of subjects who shared their gender identity than those who shared their anatomical sex., (Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
14. Coordination of healthcare for transsexual persons: a multidisciplinary approach.
- Author
-
Esteva de Antonio I and Gómez-Gil E
- Subjects
- Female, Humans, Interdisciplinary Communication, Male, Patient Satisfaction, Practice Guidelines as Topic, Plastic Surgery Procedures, Spain, Transsexualism diagnosis, Transsexualism psychology, Treatment Outcome, Health Services for Transgender Persons organization & administration, Health Services for Transgender Persons standards, Health Services for Transgender Persons trends, Hormone Replacement Therapy, Sex Reassignment Surgery standards, Transgender Persons psychology, Transsexualism therapy
- Abstract
Purpose of Review: To describe the experience in Spain concerning the public healthcare for transsexual persons using a multidisciplinary approach and to review the relevant literature. Treatment includes social and psychological support, cross-hormone treatment, and sex reassignment surgeries. Although the recommendations of The World Professional Association for Transgender Health are used as guidelines, the application of these standards of care varies considerably, probably because of specific clinical and country factors., Recent Findings: The sex reassignment process is complex and requires not only coordination of multiple procedures, but also lifetime follow-up of transsexual individuals. Gender units must provide high-quality services, been essential the principle of accessibility to resources together with a protocolized follow-up and anticipation of secondary effects from the clinical surgical treatment. Two recent challenges are juvenile gender dysphoria and gender variants, which increasingly consult professionals., Summary: Transsexualism affects all adaptive physical and psychosocial aspects of a person. As diagnosis is based only on the history and personal perceptions, a broad social debate exists about the need for treatment financed by the public health systems. Some countries restrict the care to transsexuals with private medical policies. Thus, coordination of care also requires participation of the family and associations, with continuous information to the health authorities, the judiciary, and the media of each country.
- Published
- 2013
- Full Text
- View/download PDF
15. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study.
- Author
-
Soriguer F, Gutiérrez-Repiso C, Rubio-Martín E, García-Fuentes E, Almaraz MC, Colomo N, Esteva de Antonio I, de Adana MS, Chaves FJ, Morcillo S, Valdés S, and Rojo-Martínez G
- Subjects
- Adult, Aged, Female, Follow-Up Studies, Glycated Hemoglobin analysis, Humans, Insulin Resistance, Longitudinal Studies, Male, Middle Aged, Obesity metabolism, Phenotype, Prospective Studies, Risk, Diabetes Mellitus, Type 2 etiology, Obesity complications
- Abstract
Background: Prospective longitudinal studies evaluating the relevance of "Metabolically Healthy but Obese" (MHO) phenotype at risk for type 2 diabetes mellitus (T2D) and cardiovascular diseases are few and results are contradictory., Methods: As a representative of the general population, 1051 individuals were evaluated in 1997-1998 and re-evaluated after 6 years and 11 years. Subjects without known T2D were given an oral glucose tolerance test. Anthropometric and biochemical variables were measured. Four sets of criteria were considered to define MHO subjects besides body mass index ≥30 kg/m(2): A: Homeostatic Model of Assessment-Insulin Resistance Index (HOMA-IR) <90th percentile; B: HOMA-IR <90th percentile, high-density lipoprotein cholesterol >40 mg/dL in men and high-density lipoprotein cholesterol >50 mg/dL in women, triglycerides <150 mg/dL, fasting glucose <110 mg/dL, and blood pressure ≤140/90 mm Hg; C: HOMA-IR <90th percentile, triglycerides <150 mg/dL, fasting glucose <110 mg/dL, and blood pressure ≤140/90 mm Hg; D: HOMA-IR <90th percentile, triglycerides <150 mg/dL, and fasting glucose <110 mg/dL. Subjects with T2D at baseline were excluded from the calculations of incidence of T2D., Results: The baseline prevalence of MHO phenotype varied between 3.0% and 16.9%, depending on the set of criteria chosen. Metabolically nonhealthy obese subjects were at highest risk for becoming diabetic after 11 years of follow-up (odds ratio = 8.20; 95% confidence interval = 2.72-24.72; P < .0001). In MHO subjects the risk for becoming diabetic was lower than in metabolically nonhealthy obese subjects, but this risk remained significant (odds ratio = 3.13; 95% confidence interval = 1.07-9.17; P = .02). In subjects who lost weight during the study, the association between MHO phenotype and T2D incidence disappeared, even after adjusting for HOMA-IR., Conclusions: The results suggest that MHO is a dynamic concept that should be taken into account over time. As a clinical entity, it may be questionable.
- Published
- 2013
- Full Text
- View/download PDF
16. [Clinical practice guidelines for assessment and treatment of transsexualism. SEEN Identity and Sexual Differentiation Group (GIDSEEN)].
- Author
-
Moreno-Pérez O and Esteva De Antonio I
- Subjects
- Female, Humans, Male, Transsexualism diagnosis, Transsexualism therapy
- Abstract
Transsexual patients can only be diagnosed and treated at functional gender identity Units with provision of high quality care, development of clinical practice guidelines, and interdisciplinary working groups. The therapeutic process has three mainstays: initial psychological diagnostic evaluation and psychotherapy, endocrinological evaluation and hormone therapy, and sex reassignment surgery. Cross-sex hormone therapy is essential for the anatomical and psychological transition process in duly selected patients. Hormones help optimize real-life sex identity, improve quality of life, and limit psychiatric co-morbidities often associated to lack of treatment. Development of this clinical practice guideline addresses the need for implementing a coordinated action protocol for comprehensive health care for transgender people in the National Health System., (Copyright © 2012 SEEN. Published by Elsevier Espana. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
17. [Organization of healthcare for transsexual persons in the Spanish national health system].
- Author
-
Esteva de Antonio I, Gómez-Gil E, Almaraz MC, Martínez-Tudela J, Bergero T, Olveira G, and Soriguer F
- Subjects
- Cross-Sectional Studies, Female, Humans, Male, Spain, Delivery of Health Care organization & administration, Transsexualism therapy
- Abstract
Objective: Recognition of transexuality as a clinical entity for which medical attention should be available is currently a well-established reality, but institutional care has not been uniformly instituted throughout Spain. The aim of the present study was to determine the current situation of healthcare for transexualism in the publicly-funded health service in Spain., Materials and Methods: A descriptive study based on data provided by the Spanish Society of Endocrinology Group on Identity and Sexual Differentiation was performed. The resources in the regions that have created specific gender units for these disorders are described., Results: Nine autonomous regions (55%) have started to provide various procedures, although only four provide genitoplastic procedures. The first region to include all sex reassignment surgeries was Andalusia (year 1999). At the same time, Madrid and Catalonia also began to provide specialized mental health care and endocrinology but did not include surgical procedures until 2007 and institutional recognition until 2008. Since 2007 other regions have incorporated healthcare for transsexual patients. Overall, 3,303 patients (a male-to female/female-to-male transsexual ratio of 1.9/1) and 864 surgical procedures have been registered in this study. The composition and proportion of working hours of specialists, as well as the kinds of treatments provided, differ widely in each region., Conclusions: The geographical distribution of healthcare to transsexual persons and the services provided vary. Few regions offer genitoplastic procedures. The number of applicants exceeds the number estimated by the national health system., (Copyright © 2011 SESPAS. Published by Elsevier España. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
18. [The demand for health care services in the gender identity units of Andalusia and Catalonia during the period of 2000 to 2009].
- Author
-
Gómez-Gil E, Esteva de Antonio I, Almaraz MC, Godás Sieso T, Halperin Rabinovich I, and Soriguer Escofet F
- Subjects
- Adolescent, Adult, Child, Female, Humans, Male, Middle Aged, Spain, Time Factors, Young Adult, Health Services supply & distribution, Transsexualism diagnosis, Transsexualism surgery
- Abstract
Objective: To evaluate the demand for public health services in two gender identity disorder units (Andalusia and Catalonia) during the period of 2000-2009., Method: A descriptive and comparative study was made of the demand for health services, the demographic and clinical characteristics of the patients, and the sex reassignment surgeries performed., Results: A total of 828 subjects in Andalusia and 549 in Catalonia requested clinical assistance. In both communities, the percentages of cases diagnosed of transsexualism (88 vs 89.7%), the percentages excluded in the sex reassignment program (16.7 vs 15.3%), the male/female ratio (1.6:1 vs 2.1:1), and the mean age (28 vs 29 years) were similar. A total of 284 sex-reassignment surgeries were performed in Andalusia and 50 in Catalonia., Conclusions: The demand has been maintained in Andalusia and has increased in Catalonia in recent years. The basic demographic and clinical characteristics of transsexual patients were similar between both units and comparable to those of other countries., (Copyright © 2010 Elsevier España, S.L. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
19. [Depression in type 1 diabetes mellitus and associated factors].
- Author
-
Carreira M, Anarte MT, Ruiz De Adana MS, Félix Caballero F, Machado A, Domínguez-López M, González Molero I, Esteva De Antonio I, Valdés S, González-Romero S, and Soriguer F
- Subjects
- Adult, Depression epidemiology, Diabetes Complications epidemiology, Female, Humans, Male, Risk Factors, Depression etiology, Diabetes Complications etiology, Diabetes Mellitus, Type 1 complications
- Abstract
Background and Objective: In recent years, there has been an increased interest in depression and diabetes risk factors. Our objectives were 1) Study the variables associated with the presence of depression in patients with type 1 diabetes mellitus (DM1), 2) to analyze potential risk factors for depression in these patients, and 3) to study a possible explanatory model of depression scores in these patients., Patients and Methods: 207 patients with DM1. We evaluated sociodemographic and biomedical variables by means of a structured interview. We assessed psychological variables by means of the Scale for Depression in Type 1 Diabetes (EDDI-1) and the Spanish version of Diabetes Quality of Life (Es DQOL)., Results: Prevalence of depression was 21,7%. Variables associated with risk of depression in this sample were to be female; be unemployed; smoking; having complications of diabetes or other physical conditions; not perceiving family support or support from friends or colleagues in relation to diabetes; having a high number of weekly hyperglycemia; and a poor quality of life. A model based on previous research was obtained. This model explains a high percentage of the variability in the scores of patients in the EDDI-1., Conclusions: These results provide an empirical support to the knowledge of the risk factors associated with depression in patients with DM1. Glycemic control and quality of life have an important effect on the scores of depression in these patients, providing information for their treatment., (Copyright © 2009 Elsevier España, S.L. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
20. Prevalence of obesity in south-east Spain and its relation with social and health factors.
- Author
-
Soriguer F, Rojo-Martínez G, Esteva de Antonio I, Ruiz de Adana MS, Catalá M, Merelo MJ, Beltrán M, and Tinahones FJ
- Subjects
- Adolescent, Adult, Age Factors, Body Mass Index, Educational Status, Exercise, Female, Humans, Interviews as Topic, Male, Marital Status, Middle Aged, Prevalence, Risk Factors, Risk-Taking, Socioeconomic Factors, Spain epidemiology, Health Behavior, Obesity epidemiology
- Abstract
Recent studies have confirmed important regional differences in the prevalence of obesity, as well as a tendency for this prevalence to increase. Determination of the social factors involved in obesity may be very useful to design intervention and prevention strategies. This transverse study was undertaken in Pizarra (Malaga, Spain) from a random sample of the population between 18 and 65 years of age (n = 1226). All participants were interviewed and given a physical examination. Standardized anthropometrical measurements were made, and a baseline blood sample was taken after an oral glucose tolerance test. The overall prevalence of obesity (BMI > 30 kg/m2) was 28.8%. This figure increased continuously from 10% in the group aged 18-25 years to above 50% in the groups aged over 55 years. This prevalence is higher than that reported in most other studies in Spain. The obese persons ate differently, at least from a qualitative viewpoint, probably more saturated fats and fewer unsaturated fats, and had a different behaviour concerning alcohol and smoking. Marital status was related with the rate of obesity, and the close relation between the level of education and the risk of obesity was confirmed (OR = 3.8 for being obese and having no education compared to having university studies). The most important consequence of the study was that all these factors are potentially modifiable and preventable. An increased level of general education in the population may well contribute decisively to a reduction in the prevalence of obesity.
- Published
- 2004
- Full Text
- View/download PDF
21. Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population.
- Author
-
Tinahones FJ, Gómez-Zumaquero JM, Rojo-Martínez G, Cardona F, Esteva de Antonio IE, Ruiz de Adana MS, and Soriguer FJ
- Subjects
- Adult, Aged, Blood Pressure, Cholesterol, HDL blood, Cholesterol, LDL blood, Female, Humans, Lipoproteins, LDL blood, Male, Middle Aged, Reference Values, Spain, Triglycerides blood, Autoantibodies blood, Cholesterol blood, Lipoproteins, LDL immunology
- Abstract
Autoantibodies against epitopes of oxidized low-density lipoprotein (LDL), initially shown in human sera, were later related with the atherosclerotic process, although recent studies have questioned this association. Moreover, their association with total cholesterol and plasma LDL, or with the other lipoproteins, is not clear. We studied the relation between the levels of autoantibodies to oxidized LDL and lipoproteins in a population of 400 subjects from the lower Guadalhorce area in Malaga, Spain. Anti-oxidized LDL antibodies were measured by enzyme-linked immunosorbent assay (ELISA), and total cholesterol, triglycerides, high-density lipoprotein (HDL) cholesterol, and lipoprotein(a) [Lp(a)] were measured with commercial kits. Subjects who were positive for anti-oxidized LDL antibodies had significantly lower levels of total cholesterol (P <.01) and LDL cholesterol (P <.01). There was a negative correlation between titers of anti-oxidized LDL antibodies and levels of total cholesterol (P =.007) and LDL cholesterol (P =.024). This inverse relation between the levels of anti-oxidized LDL antibodies and the levels of total cholesterol and LDL cholesterol in a large population study, together with the discordances already published, suggests that the relation between anti-oxidized LDL antibodies, arteriosclerosis, and lipids is more complex than initially thought., (Copyright 2002, Elsevier Science (USA). All rights reserved.)
- Published
- 2002
- Full Text
- View/download PDF
22. [Surreptitious intake of diuretics as the cause of pseudo-Bartter's syndrome: apropos of a case and differential diagnosis].
- Author
-
Olveira Fuster G, Mancha Doblas I, Vázquez San Miguel F, Esteva de Antonio I, and C-Soriaguer Escofet F
- Subjects
- Adult, Chlorthalidone adverse effects, Chlorthalidone blood, Chlorthalidone urine, Chromatography, High Pressure Liquid, Diagnosis, Differential, Diuretics adverse effects, Diuretics blood, Diuretics urine, Female, Furosemide adverse effects, Furosemide urine, Humans, Hypokalemia chemically induced, Bartter Syndrome diagnosis, Diuretics administration & dosage, Factitious Disorders, Hypokalemia diagnosis, Self Medication
- Abstract
We describe a 39 years old patient with a history of chronic symptomatic hypokalemia. She denied taking any drugs. She satisfied the clinical criteria for Bartter's syndrome and more precisely for Gitelman's syndrome: hypokalemia in the presence of inappropriately high potassium excretion, metabolic alkalosis, hyperreninemic hyperaldosteronism, hypomagnesemia with inappropriately high magnesium excretion, normocalcemia, hypocalciuria and normal blood pressure. A HPLC analysis detected the presence of furosemide in urine and chlorthalidone in urine and plasma samples. After the self administration of diuretics was stopped, the above alterations came back to normality. Prior to the verification of a self administration of diuretics, the patient showed clinical and biochemical parameters that oriented to surreptitious diuretic ingestion (Pseudo-Bartter's syndrome) not to Bartter's syndrome or Gitelman's syndrome, particularly the plasma potassium readily restored to normal by the administration of potassium chloride supplements, the increased plasma uric acid with low uric acid fractional clearance, the widely different urine and plasma electrolyte levels and the presence psychiatric disorders. The literature is reviewed and differential diagnosis, among this three syndromes, is made.
- Published
- 1996
23. [Diet and hypertriglyceridemia: influence of dietary modifications on plasma lipids, lipoproteins and apoproteins in patients with primary hypertriglyceridemia].
- Author
-
Soriguer Escofet FJ, Escolar Castellón JL, Esteva de Antonio I, Valdivieso Felices P, González Santos P, García Arnes J, and Tinahones Madueño F
- Subjects
- Humans, Apolipoproteins blood, Diet, Hypertriglyceridemia blood, Lipoproteins blood
- Abstract
Background: To investigate the influence of dietary changes on plasma lipoproteins and apoproteins in 10 patients with hypertriglyceridemia (plasma triglycerides greater than 1000 mg/dl)., Methods: A sequential study with three periods was designed: 1) Inclusion with uncontrolled free diet; 2) Two weeks of a diet with about 1000 calories/day, controlled with a daily survey; and 3) One week of "free" diet of about 2000 calories. At the end of the three periods the following were measured in each patient: weight, glycemia, plasma IRI and C-peptide, plasma, triglycerides, cholesterol, chylomicron, VLDL, LDL and HDL cholesterol. At the end of the second and third periods the caloric and immediate principles intake were individually considered., Results: A reduction in plasma cholesterol and triglycerides was observed in all cases after the caloric reduction, and also a disappearance of chylomicrons. The reduction of triglycerides took place in all lipoproteins. By contrast, after the low-calorie diet only the VLDL-cholesterol was reduced, while LDL- and HDL-cholesterol increased. The apo C-III/apo C-II ratio was significantly reduced after the low-calorie diet. The plasma glycemia, IRI and C-peptide were negatively correlated with LDL-cholesterol and with the apo C-III/apo C-II ratio. The best model to explain the oscillations of plasma triglycerides depending on the diet was that including the three ingested immediate principles together with the total diet calories., Conclusions: During the caloric restriction there would be an increased catabolism of VLDL to LDL. This reduction would be mediated by C-III and C-II apoproteins, probably through the oscillations of plasma IRI.
- Published
- 1992
24. [The response of the growth hormone to acute effort is a function of training].
- Author
-
Soriguer Escofet FJ, Sebastián Gil D, Campos Arillo V, Esteva de Antonio I, Romero Arias JA, Reina Cobos G, García Arnes J, Ruiz de Adana S, Martín Chazos F, and Mazuecos F
- Subjects
- Adult, Humans, Exercise physiology, Growth Hormone blood, Oxygen Consumption physiology, Physical Exertion physiology
- Abstract
Background: The increase of the growth hormone (GH) during exercise is known although the relationship of this response with other hormones, the type and intensity of the exercise, nutritional state and with the degree of training are reasons for discussion. The aim of this investigation was to study the response of the HG on a group of young adults with different degrees of training, according to the maximum consumption of oxygen (VO2 max) achieved over a short period of time., Methods: Thirty-nine healthy subjects who underwent maximum effort on the treadmill were grouped according to VO2 max reached (less than 3,000 ml/min; 3,000-4,500 ml/min and greater than 4,500 ml/min). Systolic blood pressure (SBP) and diastolic blood pressure (DBP), respiratory quotient (RQ), O2 pulse, cardiac frequency (CF) respiratory equivalence (RE), glycemia, plasma insulin (PI), C peptide, lactic acid, venous pH, plasma renin activity (PRA), plasma aldosterone, thyrotropine (TSH), triodothyronine (T3), thyroxine (T4), adrenocorticotropine (ACTH), cortisol and GH were measured basally and following achievement of VO2 max., Results: The GH was only increased in those subjects with a VO2 max higher than 3,000 ml/min with a significant positive correlation found between the GH and VO2 max and a significant negative correlation was found between the GH and lactic acid at the end of the test. The increase of glycemia at the end of the test correlated with the VO2 max. The PI and C peptide increased at the end of the test in the subjects with greater VO2 max capacity and correlated positively with the VO2 max and with the GH upon completion of the exercise., Conclusions: These results suggest that the response of the growth hormone to exercise is a function of maximum oxygen consumption although this only explains 24% of the variants of the growth hormone. Despite important hormonal and metabolic mobilization during exercise, no model of multiple regression has been found which substantially improves the association found between the growth hormone and maximum oxygen consumption.
- Published
- 1992
25. [Computerized tomography of the pituitary gland in the diagnosis of prolactinoma: a concordance study].
- Author
-
Soriguer Escofet FJ, Rodríguez Navarro MP, Rodríguez San Pedro F, Sanz JM, Esteva de Antonio I, García Arnés JA, Escolar Castellón JL, and Mazuecos F
- Subjects
- Adult, Diagnosis, Differential, Empty Sella Syndrome diagnosis, Empty Sella Syndrome diagnostic imaging, Female, Follow-Up Studies, Humans, Male, Pituitary Neoplasms blood, Prolactin blood, Prolactinoma blood, Radioimmunoassay, Regression Analysis, Time Factors, Pituitary Neoplasms diagnostic imaging, Prolactinoma diagnostic imaging, Tomography, X-Ray Computed
- Abstract
Background: The diagnostic capacity of computed tomography (CT) of the pituitary gland in the diagnosis of prolactinomas is difficult to define in terms of specificity and sensitivity since, up to the present, there is no definite diagnostic test for prolactin producing tumors. The aim of this study is to establish the consistency of CT of the hypophysis in the diagnosis of the prolactinomas based on a concordance design., Methods: In the follow-up study of 48 patients diagnosed as affected of prolactinoma a concordance study was carried out on the blind lecture of 35 pituitary gland CT by two radiologists., Results: The degree of concordance for all the diagnosis (kappa = 0.58) was greater than what might be expected by chance. The degree of concordance was also different for the different diagnosis given by the two radiologists: empty sella turcica, kappa = 0.84 (p less than 0.01); macroprolactinoma, kappa = 0.68 (p less than 0.01); microprolactinoma, kappa = 0.45 (p less than 0.01) and normal sella turcica, kappa = 0.28 (NS)., Conclusions: CT of the hypophysis must be less sensitive (more false negatives) in cases of high prolactin due to microprolactinomas and less specific (more false positives) in cases of high prolactin due to a cause other than pituitary tumor, thereby making it a complementary diagnostic test to clinical evaluation and to prolactin determinations.
- Published
- 1991
26. [Biomedical research in a regional hospital. Results of a survey].
- Author
-
Soriguer Esofet FJ and Esteva de Antonio I
- Subjects
- Spain, Surveys and Questionnaires, Attitude of Health Personnel, Hospitals, District, Hospitals, Public, Research
- Published
- 1988
27. [Fatty acids and acute pancreatitis].
- Author
-
Soriguer Escofet FJ, Esteva de Antonio I, Vicioso I, Soriguer Escofet R, and Camps García T
- Subjects
- Acute Disease, Adipose Tissue metabolism, Alcoholism complications, Biliary Tract Diseases complications, Fatty Acids analysis, Humans, Insulin metabolism, Insulin Secretion, Pancreatitis etiology, Fatty Acids metabolism, Pancreatitis metabolism
- Published
- 1983
28. [Plafibride and vascular insufficiency of the lower limbs].
- Author
-
Soringer Escofet FJ and Esteva de Antonio I
- Subjects
- Clofibric Acid therapeutic use, Drug Evaluation, Humans, Clofibrate analogs & derivatives, Clofibric Acid analogs & derivatives, Intermittent Claudication drug therapy
- Published
- 1985
29. [The glucagon test as a criterion of insulin administration in clinical practice].
- Author
-
Soriguer Escofet FJ and Esteva de Antonio I
- Subjects
- Humans, Diabetes Mellitus, Type 2 drug therapy, Glucagon, Insulin therapeutic use
- Published
- 1986
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.